Statine in der Primärprävention -- ein Muss für den Hausarzt?

Zoller, Marco
July 2011
Praxis (16618157);7/6/2011, Vol. 100 Issue 14, p859
Academic Journal
No abstract available.


Related Articles

  • Statins cost-effective even at very low risk. Cressey, Daniel // Pulse;4/19/2007, Vol. 67 Issue 15, p6 

    The article focuses on the effectivity of primary prevention with statins at very low risk. Survey shows that primary prevention is cost-effective on risk far below National Institute of Clinical Evidence (NICE) recommendations. The use of drugs was found to be cost-effective for cardiovascular...

  • NICE triggers row over rationing of statins... Wilkinson, Emma // Pulse;6/25/2005, Vol. 65 Issue 25, p1 

    Reports on the issuance of a draft appraisal by the National Institute for Clinical Excellence authorizing a limited expansion on the use of statins in Great Britain. Release of a guidance by the Joint British Society recommending statins for cardiovascular disease risk; Availability of statins...

  • Cholesterol truths Managing this risk factor. Rhéaume, Kate // Alive: Canada's Natural Health & Wellness Magazine;Feb2009, Issue 316, p120 

    The article provides information on managing high cholesterol. It is said that high cholesterol is only one risk factor for eventually developing cardiovascular disease. According to the author, taking statins to reduce cholesterol by merely blocking its production and not addressing its cause...

  • « Mit dem Wissen wächst der Zweifel ». Rosemann, Thomas // Praxis (16618157);7/6/2011, Vol. 100 Issue 14, p819 

    No abstract available.

  • Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary. Paragh, György; Márk, Lászlo; Zámolyi, Károly; Pados, Gyula; Ofner, Péter // Clinical Drug Investigation;2007, Vol. 27 Issue 9, p647 

    BACKGROUND AND OBJECTIVE: Cardiovascular disease is a leading cause of death in Eastern Europe. Few studies on cholesterol goal achievement have been conducted in Hungarian clinical settings. This study set out to evaluate lipid-modifying therapy practices and their effects on total...

  • Commentary. Bryson, Chris L.; Fihn, Stephan D. // Evidence Based Medicine;Apr2007, Vol. 12 Issue 2, p58 

    The author comments on the study on the cost and benefits of treating patients having cardiovascular diseases with a generic statin dose in Great Britain. As stated, the analyses used both event rate and cost data available from the study population. When it comes to implications for non-British...

  • Generic simvastatin would be cost effective for more people in US.  // PharmacoEconomics & Outcomes News;4/4/2009, Issue 575, p1 

    The article discusses a study of statin cost-effectiveness in the U.S. for people at different vascular risk levels. Based on the results, the Heart Protection Study (HPS) Collaborative Group believe that guidelines should be modified to extend statin treatment to a wider population. A Markov...

  • Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes. Siyambalapitiya, Sajith; Bulugahapitiya, Uditha; Sithole, Jabulani; Song, Soon; Fernando, Devaka J. S.; Idris, Iskandar // Diabetes Care;Aug2007, Vol. 30 Issue 8, p2025 

    OBJECTIVE -- Strategies for initiating statin use among adult patients with diabetes for primary cardiovascular disease (CVD) prevention include treating all patients (assuming diabetes is a coronary risk equivalent) or treating patients who are at risk of developing CVD. The aim of the study...

  • Rosuvastatin trial halted early amid fears for placebo group. Tanday, Sanjay // GP: General Practitioner;4/18/2008, p12 

    The article reports on the study undertaken by JUPITER in the U.S. which shows that the use of rosuvastatin has been more beneficial than placebo for primary prevention of cardiovascular disease (CVD). The rosuvastatin trial has been halted because participant given placebo had an increased risk...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics